Table 1.
Relation between integrin αvβ8 expression and clinicopathologic variables in colon cancer cases
| Clinicopathological factors | n (165) |
Αvβ8 expression | P Value |
|
|---|---|---|---|---|
| Positive (n=61) | Negative (n=104) | |||
| Gender | 0.227 | |||
| Male | 90 | 37 | 53 | |
| Female | 75 | 24 | 51 | |
| Age(years) | 0.072 | |||
| ≤60 | 85 | 37 | 48 | |
| >60 | 80 | 24 | 56 | |
| Tumor anatomical location | 0.787 | |||
| Right hemicolon cancer | 87 | 33 | 54 | |
| Left hemicolon cancer | 78 | 28 | 50 | |
| T stage | 0.086 | |||
| T1# | 4 | 1 | 3 | |
| T2# | 19 | 5 | 14 | |
| T3# | 66 | 19 | 47 | |
| T4# | 76 | 36 | 40 | |
| N stage | 0.007 | |||
| N0 | 93 | 26 | 67 | |
| N1 | 43 | 24 | 19 | |
| N2 | 29 | 11 | 18 | |
| M stage | 0.029 | |||
| M0 | 124 | 40 | 84 | |
| M1 | 41 | 21 | 20 | |
| TNM stage | 0.018 | |||
| I - II | 82 | 23 | 59 | |
| III-IV | 83 | 38 | 45 | |
| Differentiation | <0.001 | |||
| Well | 67 | 19 | 48 | |
| Moderate | 59 | 10 | 49 | |
| Poor/undifferentiated | 39 | 32 | 7 | |
| CD8+TILs density | <0.001 | |||
| Low | 73 | 38 | 35 | |
| high | 92 | 23 | 69 | |
| Survival (60-month follow-up) | 0.003 | |||
| Death | 78 | 38 | 40 | |
| Censored | 87 | 23 | 64 | |
*Log-rank test